Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ambroxol Hydrochloride Inhalation Solution in Pediatric Lower Respiratory Tract Infection
CTR20171483Phase 3Active
- Sponsor
- Wanbangde Pharmaceutical Holding Group
- Start
- Dec 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of ambroxol in acute bronchitis, chronic bronchitis (CB), pneumonia, Acute Respiratory Distress Syndrome (ARDS), chronic obstructive pulmonary disease (COPD), sponsored by Wanbangde Pharmaceutical Holding Group. Started Dec 2017; status: active.
02
Drugs
ambroxol
03
Conditions
acute bronchitischronic bronchitis (CB)pneumoniaAcute Respiratory Distress Syndrome (ARDS)chronic obstructive pulmonary disease (COPD)
Beyond the preview
Go deeper on CTR20171483.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20171483.